| Application no. and date | 10173956.3 (espacenet) (Federated) (European Patent Register), 20060718 | | Patent/reg. no. and date | DK/EP 2284167, 20170201 | | Publication date | 20110216 | | Priority no. and date | US 701405 P, 20050720, US 716214 P, 20050912 | | EP pub. no. and date |
EP 2284167 20110216 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | BT/GP/154815 | | Inventor | KARPINSKI, Piotr, H., 25 Terrace Parkway
Lincoln Park, NJ 07035, US,
Manley, Paul W.,
Bruggweg 12
4144, Arlesheim, CH,
WU, Raeann, 2423 Rachel Terrace
Pine Brook, NJ 07058, US,
SUTTON, Paul Allen, 34 Irvington Road
Parsippany, NJ 07054, US,
Brozio, Jörg,
Spalentorweg 20
4051, Basel, CH,
Shieh, Wen-Chung,
295 Timber Drive
Berkely Heights, NJ 07922, US,
Monnier, Stéphanie,
6, Le Parc
68190, Raedersheim, FR | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 31/506 (2006.01) , A61P 35/00 (2006.01) , C07D 401/14 (2006.01) | | Title | Krystallinsk form af 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluormethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamid | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Ændret DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
